Showing results (531-540 of 946) with videos related to
Sort By:
Pageof 95
Neuroscience|January 1, 1989
Distribution of monoaminergic, cholinergic, and GABAergic markers in the human cerebral cortexF Javoy-Agid, B Scatton, M Ruberg, et al.Neurology|December 1, 1994
Hereditary neuralgic amyotrophy and hereditary neuropathy with liability to pressure palsies: two distinct clinical, electrophysiologic, and genetic entitiesR Gouider, E LeGuern, J Emile, et al.Neurology|May 1, 1984
Biochemistry of the hypothalamus in Parkinson's diseaseF Javoy-Agid, M Ruberg, L Pique, et al.Journal of Neural Transmission. Supplementum|October 5, 2006
Neurosurgery in Parkinson's disease: the doctor is happy, the patient less so?Y Agid, M Schüpbach, M Gargiulo, et al.Neuroscience|January 1, 1989
Choline acetyltransferase-like immunoreactivity in the hippocampal formation of control subjects and patients with Alzheimer's diseaseG Ransmayr, P Cervera, E Hirsch, et al.European Journal of Human Genetics : EJHG|December 22, 1999
Multiple origins of the spinocerebellar ataxia 7 (SCA7) mutation revealed by linkage disequilibrium studies with closely flanking markers, including an intragenic polymorphism (G3145TG/A3145TG)G Stevanin, G David, A Dürr, et al.The European Journal of Neuroscience|January 29, 2000
Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological measurementsM Vila, C Périer, J Féger, et al.Brain Research|April 19, 1988
Benzodiazepine receptors in normal human brain, in Parkinson's disease and in progressive supranuclear palsyJ M Maloteaux, M A Luabeya, M A Vanisberg, et al.American Journal of Human Genetics|October 1, 1995
Marked phenotypic heterogeneity associated with expansion of a CAG repeat sequence at the spinocerebellar ataxia 3/Machado-Joseph disease locusG Cancel, N Abbas, G Stevanin, et al.Journal of Neurochemistry|March 22, 2001
Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?A Hartmann, P P Michel, J D Troadec, et al.Pageof 95